Corin Optimized Position System Functional Hip Analysis (OPS FHA)— 510(k) K190834

Name: FDA 510(k) clearance K190834
Creator: U.S. Food and Drug Administration
Published: 2019-07-22

Substantially Equivalent

Corin USA

FDA 510(k) clearance K190834 for Corin Optimized Position System Functional Hip Analysis (OPS FHA), Substantially Equivalent on 2019-07-22. Applicant: Corin USA. Device class: 2.

Clearance details

Applicant: Corin USA
Product code: Code LZO
Device class: Class 2
Regulation: 21 CFR 888.3353
Advisory panel: Orthopedic
Date received: 2019-04-01
Decision date: 2019-07-22
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Tampa, FL, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code LZO

view all

K253948 — Momentum Acetabular Cup System2026-09-02
K261009 — MobileLink Acetabular Cup System 40mm ID Inserts (various)2026-07-06
K260831 — Z1 Hip System2026-06-16
K260182 — Avenir® Müller Stem; Avenir Complete Hip System2026-04-27
K260037 — implantcast Packaging System Update2026-03-30

More clearances from Corin USA

view all

K203751 — OMNIVision system2021-04-12
K202805 — Optimized Positioning System (OPS) Insight2020-11-20
K193545 — Corin Optimized Positioning System (OPS) Femoral2020-08-04
K193042 — Optimized Positioning System (OPS) ReView2020-06-26
K192656 — Optimized Positioning System (OPS) Insight2020-05-01

Adverse events under product code LZO

product code LZO

Death: 17
Injury: 12,942
Malfunction: 1,756
Total: 14,715

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.